Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2010-1-20
pubmed:abstractText
The danger hypothesis provides a new perspective of the mechanisms underlying drug allergy. In this study, we evaluated associations between variations in the genes involved in danger signal pathways and antibiotic-induced cutaneous allergic reactions (AICARs).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1365-2222
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
39
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1852-6
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:19735272-Adolescent, pubmed-meshheading:19735272-Adult, pubmed-meshheading:19735272-Alleles, pubmed-meshheading:19735272-Anti-Bacterial Agents, pubmed-meshheading:19735272-Antigens, CD, pubmed-meshheading:19735272-Antigens, CD28, pubmed-meshheading:19735272-Antigens, CD40, pubmed-meshheading:19735272-Antigens, CD86, pubmed-meshheading:19735272-CD40 Ligand, pubmed-meshheading:19735272-CTLA-4 Antigen, pubmed-meshheading:19735272-Drug Eruptions, pubmed-meshheading:19735272-Female, pubmed-meshheading:19735272-Genetic Association Studies, pubmed-meshheading:19735272-Genotype, pubmed-meshheading:19735272-Humans, pubmed-meshheading:19735272-Interleukin-1beta, pubmed-meshheading:19735272-Korea, pubmed-meshheading:19735272-Male, pubmed-meshheading:19735272-Middle Aged, pubmed-meshheading:19735272-Polymorphism, Single Nucleotide, pubmed-meshheading:19735272-Tumor Necrosis Factor-alpha, pubmed-meshheading:19735272-Young Adult
pubmed:year
2009
pubmed:articleTitle
Allelic variants of CD40 and CD40L genes interact to promote antibiotic-induced cutaneous allergic reactions.
pubmed:affiliation
Department of Internal Medicine, Institute of Allergy and Clinical Immunology, Seoul National University College of Medicine, Seoul, Korea.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't